Long-term symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol

被引：0
|
作者：
Kane, JM
Swyzen, W
Wu, XL
McQuade, R
Esteinou, RG
Van Tran, Q
Marcus, R
Crandall, D
机构：
[1] Zucker Hillside Hosp, Glen Oaks, NY USA
[2] Bristol Myers Squibb Co, US Med Affairs, Plainsboro, NJ USA
[3] Bristol Myers Squibb Co, Biostat & Data Management, Wallingford, CT 06492 USA
[4] Otsuka Pharmaceut Co Ltd, Global Med Affairs, Princeton, NJ USA
[5] Bristol Myers Squibb Co, Global Med Affairs, Lawrenceville, NJ USA
[6] Otsuka Pharmaceut Co Ltd, US Med Affairs, Rockville, MD USA
[7] Bristol Myers Squibb Co, Pharmaceut Res Inst, Global Clin Res, Wallingford, CT 06492 USA
[8] Bristol Myers Squibb Co, Neurosci, Plainsboro, NJ USA
来源：
BIOLOGICAL PSYCHIATRY | 2006年 / 59卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
394
引用
收藏
页码：121S / 121S
页数：1
相关论文
共 50 条
  • [41] Long-term aripiprazole treatment alters smoking behavior in chronic schizophrenia patients: A pilot study
    Meyer, Jonathan M.
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S176 - S177
  • [42] Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophrenia
    Joseph P. McEvoy
    Peter J. Weiden
    Paul H. Lysaker
    Xiaowu Sun
    Amy K. O’Sullivan
    BMC Psychiatry, 21
  • [43] Long-term effect of aripiprazole lauroxil on health-related quality of life in patients with schizophrenia
    McEvoy, Joseph P.
    Weiden, Peter J.
    Lysaker, Paul H.
    Sun, Xiaowu
    O'Sullivan, Amy K.
    BMC PSYCHIATRY, 2021, 21 (01)
  • [44] LONG-TERM TOLERABILITY AND SAFETY OF ARIPIPRAZOLE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER
    Forbes, Robert A.
    Nyilas, M.
    Johnson, B.
    Aurang, C.
    Owen, R.
    Iwamoto, T.
    Carson, W. H.
    Correll, C.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 362 - 363
  • [45] Effects of long-term treatment with haloperidol, clozapine and aripiprazole on mice isolated vas deferens
    Mehmet Hanifi Tanyeri
    Mehmet Emin Buyukokuroglu
    Pelin Tanyeri
    Oguz Mutlu
    Füruzan Yildiz Akar
    Güner Ulak
    Bekir Faruk Erden
    International Urology and Nephrology, 2017, 49 : 1561 - 1567
  • [46] Long-term safety and tolerability of aripiprazole once-monthly in maintenance treatment of patients with schizophrenia
    Fleischhacker, W. Wolfgang
    Sanchez, Raymond
    Johnson, Brian
    Jin, Na
    Forbes, Robert A.
    McQuade, Robert
    Baker, Ross A.
    Carson, William
    Kane, John M.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (04) : 171 - 176
  • [47] Effects of long-term treatment with haloperidol, clozapine and aripiprazole on mice isolated vas deferens
    Tanyeri, Mehmet Hanifi
    Buyukokuroglu, Mehmet Emin
    Tanyeri, Pelin
    Mutlu, Oguz
    Akar, Furuzan Yildiz
    Ulak, Guner
    Erden, Bekir Faruk
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (09) : 1561 - 1567
  • [48] Reduction in negative symptoms of schizophrenia during long-term therapy with aripiprazole
    Archibald, DG
    Manos, G
    Tourkodimitris, S
    Iwamoto, T
    Carson, WH
    Stock, E
    Marcus, R
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 271 - 271
  • [49] Long-term effect on weight of aripiprazole-clozapine in schizophrenia patients with suboptimal response on clozapine
    Fleischliacker, W.
    Heikkinen, M. E.
    Olie, J. P.
    Dewaele, P.
    McQuade, R.
    Hennicken, D.
    Kerselaers, W.
    Landsberg, W.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S447 - S448
  • [50] Long-term treatment-emergent dyskinetic symptoms in patients treated with olanzapine and haloperidol
    Street, JS
    Tamura, R
    Sanger, T
    Tollefson, O
    PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 522 - 522
12345